Olanzapine and Pulmonary embolism - a phase IV clinical study of FDA data
Summary:
Pulmonary embolism is reported as a side effect among people who take Olanzapine (olanzapine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Sertraline, and have Psychotic disorder.
The phase IV clinical study analyzes which people have Pulmonary embolism when taking Olanzapine. It is created by eHealthMe based on reports of 68,588 people who have side effects when taking Olanzapine from the FDA, and is updated regularly.
What is Olanzapine?
Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,242 Olanzapine users. Check the latest studies of Olanzapine.
What is Pulmonary embolism?
Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 2,334 drugs and 2,956 conditions by eHealthMe. Check the latest studies of Pulmonary embolism.
68,588 people reported to have side effects when taking Olanzapine.
Among them, 940 people (1.37%) have Pulmonary embolism.
Among these 940 people:
How long have people been on Olanzapine when they have Pulmonary embolism? *
What is the gender of people who have Pulmonary embolism when taking Olanzapine? *
What is the age of people who have Pulmonary embolism when taking Olanzapine? *
What are other drugs people take besides Olanzapine? *
What are other side effects people have besides Pulmonary embolism? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Olanzapine and have Pulmonary embolism?
- Check whether Pulmonary embolism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Olanzapine:
- Olanzapine (69,242 reports)
Pulmonary embolism treatments and more:
- Pulmonary embolism (160,407 reports)
How severe was Pulmonary embolism and when was it recovered:
Expand to all the drugs that have ingredients of olanzapine:
- Pulmonary embolism and drugs with ingredients of olanzapine (1,834 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Olanzapine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pulmonary embolism:
- Pulmonary embolism (2,334 drugs)
Browse all the conditions that are associated with Pulmonary embolism:
- Pulmonary embolism (2,956 conditions)
Related publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on olanzapine (the active ingredients of Olanzapine) and Olanzapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ibuprofen cause Ovarian Cysts? - 7 seconds ago
- Tachypnea and drugs of ingredients of naproxen - 11 seconds ago
- Drug interactions of Tranexamic Acid and Locoid - 11 seconds ago
- Drug interactions of Probiotic and Magnesium Citrate - 16 seconds ago
- Could Allegra Allergy cause Lipids Abnormal? - 21 seconds ago
- Could Glipizide cause Anaphylaxis? - 22 seconds ago
- Drug interactions of Glucophage and Tykerb - 27 seconds ago
- Could Polyethylene Glycol 3350 cause Drug Abuse And Dependence? - 32 seconds ago
- Could Carbamazepine cause Gastroesophageal Reflux Disease? - 36 seconds ago
- Could Losartan cause Logorrhea? - 39 seconds ago